How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Neural Control Interface Market
- By Technology: Electroencephalography (EEG), Electrocorticography (ECoG), Intracortical Microelectrodes, Magnetoencephalography (MEG), Functional Near-Infrared Spectroscopy (fNIRS)
- By Application: Medical Rehabilitation, Neuroprosthetics, Communication Aids for Disabled, Gaming and Entertainment, Military and Defense
- By End User: Hospitals and Clinics, Research Institutes, Consumer Electronics, Military and Defense Organizations
- By Signal Processing Method: Invasive Neural Interfaces, Non-invasive Neural Interfaces, Partially Invasive Neural Interfaces
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Electroencephalography (EEG) leads By Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 274 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.165 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.173 →
Full report · locked preview
Everything inside the Neural Control Interface Market report
A complete, evidence-based study - 11 chapters and 115 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Technology 5
Application 5
End User 4
Signal Processing Method 3
Companies profiled
Neuralink Corporation
Synchron Inc.
Blackrock Neurotech
Medtronic plc
Boston Scientific Corporation
Cala Health Inc.
NeuroPace Inc.
Second Sight Medical Products Inc.
Cortec Neuro Inc.
Paradromics Inc.
Neurable Inc.
Kernel
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Neuralink Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Synchron Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Blackrock Neurotech
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Cala Health Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →NeuroPace Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Second Sight Medical Products Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Cortec Neuro Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Paradromics Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Neurable Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Kernel
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →BrainCo Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →NeuroSigma Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →NeuroSky Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,255M by 2033 · 5.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Electroencephalography (EEG)47.7
- Electrocorticography (ECoG)11.2
- Intracortical Microelectrodes8.8
- Magnetoencephalography (MEG)17.3
- Functional Near-Infrared Spectroscopy (fNIRS)15.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$907.7M → $1,403M · 5.6%
Europe$632.7M → $1,101M · 7.2%
Asia Pacific$577.6M → $928.0M · 6.1%
Latin America$357.6M → $567.7M · 5.9%
Middle East and Africa$275.1M → $473.6M · 7.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.572026
5.582027
5.592028
5.592029
5.612030
5.612031
5.622032
5.642033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Neuralink Corporation23.7
- Synchron Inc.15.2
- Blackrock Neurotech10.3
- Medtronic plc5.8
- Boston Scientific Corporation9.5
- Cala Health Inc.7.4
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology33.4%
Application24.8%
End User19.7%
Signal Processing Method22.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.4
- Europe24.6
- Asia Pacific20.7
- Latin America12.7
- Middle East and Africa10.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Neuralink Corporation | 75 | 91 | 82 | 74 | 79 | 93 | 82 |
| Synchron Inc. | 92 | 82 | 73 | 87 | 73 | 73 | 80 |
| Blackrock Neurotech | 85 | 86 | 76 | 69 | 82 | 76 | 79 |
| Medtronic plc | 59 | 79 | 76 | 75 | 61 | 82 | 72 |
| Boston Scientific Corporation | 76 | 56 | 72 | 73 | 69 | 54 | 67 |
| Cala Health Inc. | 56 | 66 | 63 | 56 | 56 | 47 | 57 |
| NeuroPace Inc. | 59 | 50 | 43 | 57 | 50 | 51 | 52 |
| Second Sight Medical Products Inc. | 52 | 51 | 48 | 37 | 53 | 52 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Neuralink Corporation
- Synchron Inc.
- Blackrock Neurotech
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Neuralink Corporation | ✓ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Synchron Inc. | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Blackrock Neurotech | ✓ | ✓ | ◐ | − | ✓ | ✓ |
| Medtronic plc | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Boston Scientific Corporation | ✓ | − | ◐ | − | − | ◐ |
| Cala Health Inc. | − | ◐ | ◐ | − | − | − |
| NeuroPace Inc. | ◐ | − | − | − | − | − |
| Second Sight Medical Products Inc. | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Neuralink Corporation82
2Synchron Inc.80
3Blackrock Neurotech79
4Medtronic plc72
5Boston Scientific Corporation67
6Cala Health Inc.57
7NeuroPace Inc.52
8Second Sight Medical Products Inc.49
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Neuralink CorporationSynchron Inc.Blackrock Neurotech
Challenger2
Strong scale, closing on the leaders.
Medtronic plcBoston Scientific Corporation
Contender1
Focused players with pockets of strength.
Cala Health Inc.
Niche2
Specialists in a single segment or region.
NeuroPace Inc.Second Sight Medical Products Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Technology in North America, then scale across Neural Control Interface Market — a $855M beachhead inside a $11.4B market.
Beachhead (SOM)$855Mobtainable near-term
Serviceable (SAM)$4.52Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Electroencephalography (EEG)
Best fit — highest urgency & budget in Technology.
Economic buyer78 fit
Electrocorticography (ECoG)
Strong fit — clear ROI and a fast path to value.
End user69 fit
Intracortical Microelectrodes
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel27%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Neural Control Interface Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified22%
Evaluation12%
Closed-won8%
$11.2KCAC
$61KLTV
5.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Neural Control Interface Market is a durable-growth opportunity — $2.57B by 2033, compounding at 8.5%.
TAM · 2025$1.34Btoday
TAM · 2033$2.57Bforecast
CAGR8.5%2027–2033
Cumulative$17.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.57BTotal addressable market
SAM$1.03BServiceable available market
SOM$203MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.5% CAGR
Demand compounds through 2033, outpacing GDP across Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.57BLarge & growingTAM by 2033 at 8.5% CAGR
$1.03BServiceable nowreachable with today’s model
$203MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.01BBear5.5% CAGR
$2.57BBase8.5% CAGR
$3.29BBull11.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Neural Control Interface Market — a $10.0B market by 2033. Plan: grow share from 8.0% to 17.3%.
Market size · 2033$10.0Btotal addressable
Market CAGR10.8%2027–2033
Target share17.3%from 8.0% today
Revenue ambition$1.74Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.0% | 17.3% | At risk |
| Revenue | $779M | $1.74B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 35.2% | 41.7% | On track |
| Customer retention | 89.5% | 96.8% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $198M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Neural Control Interface Market conversation — a $8.39B market you can size, segment and defend in minutes.
Market size · 2033$8.39Btotal opportunity
Growth7.0%CAGR to 2033
Addressable buyers1,361+accounts in scope
Typical ROI4.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology
Goal Grow share in Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.8×return on cost, year one
< 3 mopayback period
$52K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Neuralink CorporationSynchron Inc.Blackrock NeurotechMedtronic plcBoston Scientific CorporationCala Health Inc.NeuroPace Inc.Second Sight Medical Products Inc.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Neural Control Interface Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Neural Control Interface Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →NeuN Antibody Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportNeulasta (Pegfilgrastim) and Biosimilar Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportNEU3 Antibody Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportNetwork Point-of-Care Glucose Testing Device Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportNetworked Pulse Oximeter Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportNetworked Pill Box Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportNetworked Glucose Meter Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportNetupitant and Palonosetron Hydrochloride Capsules Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportNeti Pots Market
Market size, share, segmentation and regional forecast.
$407M market · 2025 base year
View reportNetilmicin Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportNetherton Syndrome Treatment Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportNetherton Syndrome Market
Market size, share, segmentation and regional forecast.
$855M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.